Internal Medicine - Issue 1/2018
Reviews
17
Diabetic dyslipidemia and microvascular complications of diabetes
David Karásek, Helena Vaverková
25
30
Epidemiology of hypercholesterolemia
Barbora Nussbaumerová, Hana Rosolová
38
MedPed – the reality of familial hypercholesterolemia care at the biggest center
Martina Vaclová, Tomáš Freiberger, Lucie Schwarzová, Lukáš Tichý, Michal Vrablík, Richard Češka
43
The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?
Vladimír Bláha, Milan Bláha, Miriam Lánská, Eduard Havel, Pavel Vyroubal, Zdeněk Zadák, Pavel Žák
51
Cardiovascular risk in patients with rheumatic disease and its management
Jiří Laštůvka, Sabína Oreská, prof. MUDr. Michal Tomčík, Ph.D., Michal Vrablík
61
Examination methods for coronary atherosclerosis regression with special focus on GLAGOV trial
Tomáš Kovárník, Karel Kopřiva, Jan Pudil
66
Effect of pulsatility on markers of vascular damage in patients with implanted continuous flow mechanical circulatory support
Peter Ivák, Jan Piťha, Ivana Králová Lesná, Ivan Netuka
72
Remarks on biomarkers of cardiovascular risk
Janka Franeková, Antonín Jabor
77
Long non-coding RNAs in the pathophysiology of atherosclerosis
Jan Novák, Julie Bienertová Vašků, Miroslav Souček
83
Internal Medicine
2018 Issue 1
Most read in this issue
- Familial combined hyperlipidemia – the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease
- Epidemiology of hypercholesterolemia
- Diabetic dyslipidemia and microvascular complications of diabetes
- The current position of hydrochlorothiazide among thiazide and thiazide-like diuretics